Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06204900 · ClinicalTrials.gov registry record · NA
A Post-marketing Study to Evaluate a Novel Surgical Monitoring Technique Using the EARP Nerve Cuff in TLIF Surgery.
A NA study of Transforaminal Lumbar Interbody Fusion Surgery, sponsored by Retropsoas Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT06204900 is a NA study of Transforaminal Lumbar Interbody Fusion Surgery that is actively recruiting participants, run by Retropsoas Technologies. The registered enrollment target is 30 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT06204900, a NA study of Transforaminal Lumbar Interbody Fusion Surgery, is actively recruiting participants, sponsored by Retropsoas Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the differences (the effectiveness and the safety) between two different nerve and muscle monitoring devices currently available during a TLIF surgery. The Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor surgical and nerve monitoring tools will be used in addition to standard nerve monitoring tools during the surgery. The choice of standard nerve monitoring equipment is based on the decision of the surgeon and technologist and is not dictated by this study. These tools will be compared with regards to safety and ability to accurately monitor the nervous system during the surgery.
Conditions Studied
Interventions
- DEVICE Nerve Cuff and Retractor System
Study Locations (2)
Pennsylvania
- Rothman Orthopaedic Institute - Philadelphia
- Allegheny-Singer Research Institute - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2025-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06204900
The ClinicalTrials.gov registry entry for NCT06204900 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Retropsoas Technologies, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transforaminal Lumbar Interbody Fusion Surgery appearing as the primary indexed condition, and to 1 intervention - of which Nerve Cuff and Retractor System is the first listed.
NCT06204900 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06204900 about?
NCT06204900 is a clinical study titled "A Post-marketing Study to Evaluate a Novel Surgical Monitoring Technique Using the EARP Nerve Cuff in TLIF Surgery.". The purpose of this study is to evaluate the differences (the effectiveness and the safety) between two different nerve and muscle monitoring devices currently available during a TLIF surgery. The Endoscopic Assisted Retropsoas (EARP) Nerve Cuff Electrode and Retractor surgical and nerve monitoring...
What is the current status of trial NCT06204900?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-07. Estimated completion is 2025-07.
What conditions does trial NCT06204900 study?
This clinical trial studies the following conditions: Transforaminal Lumbar Interbody Fusion Surgery.
What interventions are being tested in trial NCT06204900?
The interventions under investigation include: Nerve Cuff and Retractor System (DEVICE).
Who is sponsoring clinical trial NCT06204900?
This trial is sponsored by Retropsoas Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06204900 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.